Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cayman Chemical 1 2 3TrIdocosahexaenoyl Glyc

Supplier: Cayman Chemical 23152250 MG

A selective inhibitor of mutant EGFR that exhibits a 298-fold increase in potency compared with wild-type EGFR oral administration at 500 mg/kg regresses tumors with EGFR-active and T790M mutations in a xenograft model

Catalog No. 50-298-7599

Product Suggestions

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

Your Name

Email Address *

Type of Issue *

Detailed Description of Issue/Request *

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

Your feedback has been submitted: Thank you for helping us improve our website.

Spot an opportunity for improvement?Share a Content Correction

Cayman Chemical 1 2 3TrIdocosahexaenoyl Glyc

A selective inhibitor of mutant EGFR that exhibits a 298-fold increase in potency compared with wild-type EGFR oral administration at 500 mg/kg regresses tumors with EGFR-active and T790M mutations in a xenograft model

Description

Product Suggestions

Documents

Promotions